Your Shoulder Isn't Failing to Respond to Treatment. The Treatment Has Been Failing Your Shoulder.

A recently retired NHS Consultant Shoulder Surgeon on the circulatory problem that Naproxen, cortisone, and physiotherapy all miss — and why every month you spend getting on with it is narrowing the window for non-surgical recovery.

Mr Robert Ashworth in his NHS consulting room. After twenty-seven years and over four thousand shoulder operations, he found that the standard pathway was missing the one mechanism that determines whether conservative management works.

There is something I observed in my outpatient clinic for twenty-seven years that I never found a polite way to address directly.

Men do not accurately describe their shoulder pain.

I do not mean they lie, precisely. I mean that when a man in his late fifties sits across from me and I ask him on a scale of one to ten how bad the pain is, he gives me a number that is, in my consistent clinical experience, lower than the truth. The men who attend their appointments with their wives are frequently corrected. Quietly. From the chair beside them. The wives tend to know the actual number.

I have been a consultant orthopaedic surgeon for twenty-seven years. I have operated on over four thousand shoulders. In that time I developed a reasonable ability to read the gap between what a male patient was reporting and what was actually happening. A man who scores himself at three or four, who has not mentioned night pain, who has rearranged the tools in his garage to waist height on a Saturday afternoon without explaining why to his wife — that man is at six or seven. Possibly eight.

I am writing this because the gap between what men report and what men are experiencing has a consequence that the NHS pathway is not designed to address. And because getting on with it — the default male response to shoulder pain in this country — is not neutral. It is making the problem worse.

In the watershed zone of the supraspinatus tendon, oxygen deprivation triggers a process called fibrotic substitution. Healthy, elastic collagen fibres are progressively replaced by inelastic scar tissue. This process has a direction. It does not reverse on its own. Every month that the tissue remains oxygen-starved, the ratio of functional collagen to fibrous tissue worsens. The mechanical threshold at which your consultant recommends surgical intervention moves closer.

The man who addresses this now is in a meaningfully different clinical position to the man who addresses it in six months. Not different in the way that feels different day to day. Different in the way that determines what options remain available.

Let me describe the male pattern of shoulder management that I saw, repeatedly, across two and a half decades of NHS orthopaedic practice.

A man in his late fifties or sixties develops pain in his right shoulder — typically the dominant arm. Rotator cuff degeneration, subacromial impingement, adhesive capsulitis. He does not book a GP appointment immediately. He gives it a few weeks. Then a few months. He takes Ibuprofen from the kitchen cupboard and gets on with it.

Eventually — three, six, sometimes nine months later — he books a GP appointment. He describes the pain at a level that is considerably lower than the reality. He is prescribed Naproxen. He is referred to physiotherapy with a wait time of eight to twelve weeks.

He reorganises his life around the limitation. Not dramatically. Not in a way anyone would necessarily notice if they were not paying close attention. He stops reaching for things on the high shelves. He puts the car in reverse by turning the wheel with one hand. He stops carrying the heavier bags. He sleeps on the unaffected side, or eventually, if the night pain becomes reliable, he moves to the armchair in the sitting room so he does not wake his wife.

He does not describe any of this as a significant development.

When I ask, at the clinic appointment, what the pain prevents him from doing, he says: "Not much, really. It's more of a nuisance."

His wife, when present, provides a more accurate inventory.

He carved the lamb left-handed. He is right-handed. He has been right-handed his entire life. He did not mention having switched. No announcement, no complaint, no explanation.

My brother-in-law David is sixty-two. He spent thirty-three years as a site manager on construction projects across the Midlands. He is a man who has not, in the time I have known him, described physical discomfort as a notable concern.

He came to us for Christmas dinner two years ago. He carved the lamb left-handed.

He is right-handed. He has been right-handed his entire life. He did not mention having switched. No announcement, no complaint, no explanation. He had simply — at some point in the preceding eight months — learned to manage the carving knife with his left hand, and had done so at our Christmas table without, apparently, considering it worth raising.

I noticed. I said nothing at the time. After dinner, I asked him when the shoulder had started. He said: "A while back." I said: "On a scale of one to ten—" He said: "Three or four, maybe." His wife, from the other room, said: "Seven or eight, Robert. He's been sleeping downstairs since September."

He had been getting on with it for eleven months. The cortisone injection he'd had at a private clinic the previous spring had provided three weeks of relief. He had not gone back because the appointment cost £280 and, in his assessment, the return had not justified the investment.

What David had already tried. Every item on the left is a treatment that addresses the symptom — not the source. None of them restore circulation to the watershed zone. That is the problem the standard pathway is not designed to solve.

The Naproxen. Taken every morning for fourteen months. His GP had added Omeprazole six months in when David mentioned his stomach had become "a bit unreliable." One drug generating the need for a second. Neither addressing the shoulder at its source.

The cortisone injection. Three to four weeks of genuine relief. Then regression. He had been advised against a second injection given the clinical evidence on tendon degeneration with repeated steroid exposure. He left the appointment with a leaflet.

The Ibuprofen gel from Boots. Applied at night. He described it as "marginally useful." The joint capsule sits two to three centimetres below the skin surface. Topical gels do not penetrate to the joint capsule. Marginally useful was, from a physiological standpoint, approximately correct.

The exercise sheet. He had attempted it for eleven days. Three of the six exercises produced immediate pain flares. He stopped. This was, from a clinical perspective, the appropriate response — performing resistance exercises on an acutely inflamed joint at this stage of the condition is contraindicated in several peer-reviewed papers the NHS pathway does not appear to have read in some time.

The getting on with it. Eleven months of it. And a shoulder that was, by any objective clinical measure, meaningfully worse than when he had started.

In the last three years before retirement, Mr Ashworth began reading outside the surgical literature — sports medicine, military rehabilitation research, Scandinavian physiotherapy studies. What he found was professionally uncomfortable.

In the last three years before I retired, I had begun reading outside the surgical literature. Sports medicine. Military rehabilitation research. Physiotherapy studies from Scandinavia and Germany that the NHS, for reasons of resource and time, had not implemented.

What I found was professionally uncomfortable.

The core problem in rotator cuff degeneration is not primarily a structural problem. It is a circulatory one.

The watershed zone: 10–15mm from the tendon insertion, with almost no baseline blood supply in healthy adults. As the shoulder becomes inflamed and the joint capsule contracts, this zone becomes progressively starved of oxygen. Without oxygen, the tissue cannot repair. The Naproxen, the cortisone, the physio exercises — none of them address this.

What the research showed — and what military rehabilitation physicians had been applying in field hospitals since the 1940s — was that three specific physical mechanisms, applied simultaneously and consistently, could restore microvascular circulation to ischaemic tendon tissue, reduce synovial fluid viscosity, and desensitise the inflamed nerve endings.

All three mechanisms, simultaneously, directly on the shoulder tissue, every day. Miss any one of them and the mechanism is incomplete.

The device is a single-unit sleeve that slides onto the shoulder from the front. You do not raise the affected arm above waist height. One lateral Velcro closure. One button. Twenty minutes. You read the paper. You watch the news. You have your morning tea. You take it off. You carry on with your day.

The device is a single-unit sleeve that slides onto the shoulder from the front. You do not raise the affected arm above waist height. You do not reach behind you. You do not grip or pull with the affected hand. You do not require bilateral movement of any kind. It features a single lateral Velcro closure that fastens against the body using the good arm. One button.

The entire application takes approximately thirty seconds and requires no overhead movement, no strap-pulling, no contortion. It was designed with that as the non-negotiable requirement — that it must be fully operable by a man with one functional arm and a shoulder that can barely move, without assistance, without embarrassment, and without making the condition worse to apply the treatment.

You slide it on. You press the button. You read the paper. You watch the news. You have your morning tea. Twenty minutes. You take it off. You carry on with your day.

I brought a device home for David in January. It had been sourced through a former colleague in sports medicine who had been using it in his private clinic. UK-distributed, under one kilogram, designed for exactly the population I have described.

David used it with minimal enthusiasm. He told me, at the two-week mark, that it seemed to be "doing something." Coming from David, that is an endorsement of considerable warmth.

By week three, he called to tell me he had slept in the bed rather than the armchair the previous two nights. He reported this in the tone of a man describing a moderately satisfactory planning outcome.

By week six, he had stopped the morning Naproxen. The Omeprazole — which he had been taking every morning for eight months to protect his stomach from the Naproxen — went in the bin the following week. His wife called to tell me his digestive symptoms had resolved. David did not call about that himself.

By week ten, he was back on his construction sites doing the work he had been quietly avoiding. He called to tell me the shoulder was "basically sorted." He used the right hand to carve the meat at a family lunch in March. He did not mention this either. I know because his wife told me.

Let me ask you what I am, after twenty-seven years, in a reasonable position to ask. How much have you spent in the last two or three years on a shoulder that is no better — and probably worse — than when you started?

Treatment	Typical UK Annual Cost	What It Actually Does
Daily Naproxen	£120–180	Masks the signal. Doesn't restore circulation.
Omeprazole (to protect stomach from Naproxen)	£40	Treats the damage caused by the treatment
Private GP appointments (4/year)	£280–320	Ten minutes. Same advice as NHS.
One course private physiotherapy	£480–720	Strengthens muscles. Ischaemic tissue still ischaemic.
Cortisone injection (private, 1/year)	£200–350	3–6 weeks relief. Accelerates tendon degeneration.
Ibuprofen gel (Boots)	£40–80	Doesn't reach the joint capsule.
Annual total (typical)	£1,940–2,750	A shoulder that is no better. Often a stomach that is worse.
Private shoulder surgery	£12,000–17,000	1 in 4 patients report residual chronic pain twelve months post-operatively.
VitalCell™ Shoulder Recovery System	£64.90 (one-time)	Three mechanisms simultaneously. 90-day guarantee. Operable with one arm.

Less than a single cortisone injection at a private clinic. Less than two months of the Naproxen and Omeprazole combined. A fraction of the cost of the surgery you may be on a waiting list for.

"Gate's done, by the way." The job that had been deferred for two years. Right arm throughout. He mentioned it almost as an afterthought.